PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Cambridge spin-out PharmEnable raises £1.8m for drug discovery

Cambridge spin-out PharmEnable has closed a £1.8-million seed financing to support its transition into a drug development company. The company is aiming to develop...
Continue Reading →
News

Vertex signs ‘landmark’ deal with NHS for CF therapy

Vertex has reached an agreement with NHS England to reimburse its triple combination therapy Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco ...
Continue Reading →
News

CMA imposes £1.2m fines for price-fixing in private eye care

Spire Healthcare and Spire Healthcare Group (Spire) has admitted that one of its hospitals 'instigated and facilitated' an illegal arrangement with seven consultant ...
Continue Reading →
News

US approves Bavencio for bladder cancer

EMD Serono, the biopharmaceutical business of Merck KGaA, and Pfizer today announced that the US Food and Drug Administration (FDA) has expanded use of Bavencio (ave...
Continue Reading →
News

Final NICE green light for Janssen’s Stelara in UC

The National Institute for Health and Care Excellence (NICE) has now issued a final green light for NHS use of Janssen's Stelara (ustekinumab) to treat ulcerative co...
Continue Reading →
News

GSK and IDEAYA partner in synthetic lethality

GlaxoSmithKline and IDEAYA Biosciences have announced a strategic partnership in synthetic lethality, an emerging arm of oncology and a core research focus for GSK. ...
Continue Reading →
News

MHRA suspends COVID-19 hydroxychloroquine trials

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is suspending recruitment of patients in clinical trials involving hydroxychloroquine. The move...
Continue Reading →
News

Dexamethasone cut deaths by 35% in ventilated COVID-19 patients

As of this morning – Wednesday June 17 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 298,136 with 41,969 deaths. Data from the...
Continue Reading →
News

Jazz’ small cell lung cancer therapy wins US green light

Jazz Pharmaceuticals and PharmaMar have announced US approval of Zepzelca (lurbinectedin) for the treatment of adults with metastatic small cell lung cancer (SCLC) w...
Continue Reading →
News

ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials

Combining APDM’s precision motion wearables and digital biomarkers with ERT’s eClinical Suite revolutionizes clinical trials ERT, the global leader in clinical end...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026